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The CALC-1 gene exhibits tissue specific alternatlve splicing with exons 14 being sphced to produce the calcitonin mRNA m thyroid C cells and 
exons l-3 and 5-6 being joined to produce the CGRP mRNA in neuronal cells. Previous studies have identified an element in intron 3 within the 
alternatively spliced region which is crltlcal for this effect to occur. We show here that deletion of sequences downstream of the alternatlvely spliced 
region also disrupts the tissue specific pattern of alternatlve splicmg. The manner m which these sequences act is discussed. 
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1. INTRODUCTION 
Alternative splicing is a form of post-transcriptional 
regulation allowing the generation of different sets of 
related polypeptides in different cell types. This thereby 
increases the coding capacity of the genome and is a 
means of regulating gene expression which is particu- 
larly widely used in non-dividing cells such as neurons 
where the reprogramming of gene transcription by al- 
tering chromatin structure is difficult (for reviews see 
[la. 
The CALC-1 gene of both rat [3] and human [4] is 
alternatively spliced in a tissue specific manner and has 
served as a model system for studying the processes 
regulating tissue specific patterns of alternative mRNA 
splicing. Thus this gene is transcribed only in thyroid C 
cells and in neuronal cells in the brain. In thyroid cells 
exons 14 are spliced together to produce the calcitonin 
mRNA whereas in neuronal cells exon 4 is omitted and 
splicing of the common exons l-3 with exons 5 and 6 
produces the CGRP mRNA (3, Fig. 1). Transfection of 
different cell types with a CALC- 1 construct containing 
exons l-6 and the polyadenylation sites for both 
mRNAs reproduced the correct in vivo splicing pattern 
and suggested that a specific trarzs-acting protein pres- 
ent in only a limited range of cell types was required to 
inhibit calcitonin-specific splicing and hence allow 
CGRP-specific splicing to occur [5,6]. Subsequent stud- 
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ies identified a c&acting element near the 3’ splice site 
of intron 3 which was required for the tissue specific 
inhibition of calcitonin-specific splicing [7]. 
Based on these studies several investigations have 
used truncated mini gene constructs containing this re- 
gion in studies of CALC-1 alternative splicing. Thus a 
construct containing exons 6-6 and both polyadenyla- 
tion signals yielded the correct tissue-specific pattern of 
alternative splicing suggesting that exons l-3 are not 
required for regulation of the splicing event [8]. It has 
also been suggested that a construct truncated within 
exons 3 and 5 and lacking both proximal and distal 
sequences as well as the CGRP-specific polyadenylation 
site contained all the sequences required for regulated 
alternative splicing [9]. This construct has therefore 
been used for several studies on the mechanisms mediat- 
ing such splicing (see for example [lo]). However, in 
vitro experiments with this construct led to the produc- 
tion of the CGRP mRNA in several cell lines which 
normally produce the calcitonin mRNA [9] suggesting 
that sequences in the distal portion of the gene may be 
necessary for the correct regulation of the alternative 
splicing event. 
To resolve this problem, we have directly compared 
the splicing pattern produced by transfection of differ- 
ent cell types with two constructs containing portions 
of the human CALC-1 gene expressed under the control 
of the RSV promoter. One of these constructs (pRSV- 
Ca13) contains exons 3-6 with the corresponding in- 
trons and both polyadenylation signals whereas the 
other (pRSV-Ca12) is truncated in exon 5 and therefore 
lacks part of exon 5, all of intron 5 and exorr6 as well 
as the CGRP polyadenylation signal which is replaced 
by that of SV40 (Fig. 1). 
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2. MATERIALS AND METHODS 
2.1. Cell culture 
ND3, HeLa and 3T3 cells were grown in DMEM (Gibco BRL wtth 
0.11 g/l sodium pyruvate) supplemented wtth 10% v/v foetal calf serum 
(Gtbco BRL) and ND7 cells were grown in L15 (Ltebovttz) medium 
(Gibco BRL with L-glutamine) supplemented with 10% v/v foetal calf 
serum, 0.35% w/v sodium bicarbonate and 0.35% w/v glucose 
Human calcitonin/CGRP-1 minigene constructs were transfected 
by the calcium phosphate procedure of Gorman [ 1 I]. Cells were seeded 
at a density of 8 x IO’/90 mm plate. 
2.3. RNA analysu 
Total RNA was isolated from transfected or untransfected tissue 
culture cells by a raped guanidimum isothtocyanate method [12]. Prior 
to reverse transcription mRNA was typically treated with 15 units of 
DNase I and 20 units of RNase inhibitor (Rnasm) m 50 ~1 of dH,O 
for 1 h at 37°C to remove traces of genomtc DNA. mRNA was then 
extracted with phenol/chloroform and chloroform and ethanol precip- 
itated. 
Reverse transcription was carried out typically m a 20 pg volume 
containing 1 pg of total mRNA, 0.25 umts of random hexanucleottdes, 
0.5 mM dATP, dCTP. dGTP and TTP (Pharmacia). 1 x Taq DNA 
polymerase buffer (Amersham). 12 mM DTT, 100 umts of M-MLV 
reverse transcriptase and 20 units of Rnasin and Incubated at 37°C 
for 1 h 
PCR analysis of cDNA was carried out by the method of Kawasaki 
[13]. Reactions were typically m a 50 ~1 volume contammg 30 pmol 
of each primer. 0.1 mM dATP, dCTP. dGTP and TTP, 1 x Taq DNA 
polymerase buffer (Amersham) and 2 umts of Taq DNA polymerase. 
Following PCR amphfication using a Hybatd thermal reaction. sam- 
ples were extracted with 50 ,uI of chloroform and loaded onto agarose, 
ethidtum bromide gels. 
In prehmmary experiments PCR amplificattons were carried out 
using different cDNA diluttons and numbers of cycles to identify 
conditions in which the PCR product signal was linearly related to the 
input cDNA. 
PCR amphfication of calcitonin/CGRP-1 cDNA from cells trans- 
fected with pRSV-Cal? or PRSV-Cal3 were carried out usmg a sense 
oligonucleotide dertved from the RSV mRNA 5’-untranslated se- 
quence (5’-CCATTCACCACATTGGTGTGC-3’. sequence derived 
from [4], and the anttsense oligonucleottdes. h-Cal 4 (5’-TAC- 
CAGCCCAAAGAGCCACC-3’) and h-CGRPS (5’-TGGAACCCA- 
CATTGGTGGGC-3’) the sequences of which were both derived from 
Broad et al. [I 51 30 cycles were carried out at 93°C for 45 s. 64°C for 
45 s and 72°C for 45 s. The resultmg products were separated on 1.75% 
agaroselethidtum bromide gels. 
2.4 Southerrr blottrrly 
DNA was transferred onto hybond N agarose/ethtdtum bromide 
gels. Filters were prehybrtdised in 6 x SSC, 10% w/v dextran sulphate 
(Pharmacia). 0.1% w/v SDS, 5 x Denhardts and lOO,~g/ml denatured 
herring sperm DNA (Sigma). for 2 h at 65°C. Oligo labelling of DNA 
fragments was carried out accordmg to the method of F&berg and 
Vogelstem [16]. Hybrtdisation to denatured, oligo-labelled probe was 
carried out in the same solution overnight at 65°C. 
After hybridization filters were washed to a stringency of 
0.25 x SSC and 0.1% SDS. The probe used for detection of both PCR 
products was derived from exon 3 of pRSV-Cal3 by HpaIIBanzHI 
digestion and the resulting 173-bp product has complementary with 
the PCR products through 67% of its length. The probe used for 
calcitonin PCR product detection was derived from exon 4 of pRSV- 
Cal3 by &$I, NsrI digestton. and the resulting 237-bp product WiS 
100% complementary with the PCR product, The probe used for 
CGRP PCR product detection was derived from exon 5 of pRSV-Cal3 
by Bg/II. NarI digestion and the resulting 168-bp product was comple- 
mentary with the PCR product through 72% of its length. 
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Ftg 1. Schematic diagram of the pRSV Cal 2 and Cal 3 mini-gene 
constructs, alternative processmg of the calcitonm/CGRP pre-mRNA 
and the nature of the PCR assay. Small arrows indicate the positions 
of the primers used in the PCR assays. Bars indicate the regions used 
to prepare probes which will hybridize to only the calcitonin-specific 
product (2371, only the CGRP-spectfic product (1681 or to both prod- 
ucts (I 73). 
3. RESULTS AND DISCUSSION 
In order to test the splicing pattern produced by the 
pRSV Cal 2 and Cal 3 constructs they were transfected 
into various cell types. RNA was then prepared from 
the cells and used to prepare cDNA which was then 
amplified by the polymerase chain reaction (PCR) using 
a common sense oligonucleotide derived from the RSV 
5’-untranslated region and anti-sense oligonucleotides 
specific for the calcitonin and CGRP-mRNAs (derived 
from exons 4 and 5, respectively). The PCR products 
were then electrophoresed on an agarose gel, blotted 
onto nitrocellulose and probed with probes specific for 
the calcitonin or CGRP product. The PCR products 
were shown to be derived from the expected regions by 
restriction enzyme digestion whilst the PCR amplifica- 
tion was shown to be quantitative relative to input 
cDNA in a dilution experiment (Fig. 2a). 
When the ratio of calcitonin to CGRP-specific splic- 
ing was quantitated by scintillation counting of the la- 
belled bands on the Southern blot (Fig. 2b and c), the 
Cal 3 construct produced the expected pattern with the 
neuronal cell lines ND3 and ND7 producing predomi- 
nantly CGRP-specific splicing whilst the non neuronal 
3T3 and HeLa cells produced predominantly calcitonin- 
specific splicing. In contrast transfection of the Cal 2 
construct prevented the efficient production of CGRP 
transcripts even in cells which predominantly produces 
such transcripts when transfected with the Cal 3 con- 
struct. 
Hence the Cal 3 construct contains all the sequences 
necessary for the correct splicing pattern of the Calc-1 
gene with the ND3 and ND7 line producing predomi- 
nantly CGRP transcripts as occurs in neurons in the 
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Fig. 2. (a) Agarose/ethidium bromide gel showmg amplification of a 
dilution series of cDNA derived from ND7 cells transfected with 
pRSV-Ca13. Amplification was carried out with the RSV sense primer 
and the h-Cal 4 and h-CGRPS primers to detect the products of both 
calcitonin and CGRP-specific sphcing of the RNA produced by 
pRSV-Ca13. Numbers represent ,uI of input cDNA. 1 ,uI of cDNA was 
used in subsequent assays. The calcitonin and CGRP-specific prod- 
ucts are indicated. Cal+ is a band amphfied by the RSV and h-Cal 4 
oligonucleotide primers and is derived from plasmid DNA or un- 
spliced precursor RNA. (b) Duplicate southern blots of calcitonin and 
CGRP-specific PCR products probed with probes specific for each 
product, The calcitonin positive control is a 483 bp BgrII fragment 
derived from exon 4 whilst the CGRP positive control is a 231 bp 
N~oIIP~uII fragment derived from exon 5 Results are shown for cells 
transfected with either Cal 2 (2) or Cal 3 (3) or for untrdnsfected cells 
(-). (c) Bar chart obtained from the data in panel a. Cell lines which 
carry out predominantly calcitonin-specific splicing are represented by 
bars above the origin whilst cells carrying out predommantly CGRP- 
specific sphcing are represented by bars below the origin. 
brain in vivo [6] whilst 3T3 fibroblasts and HeLa epithe- 
lial cells produce predominantly calcitonin transcripts 
as occurs in other cell types in vivo [6]. In contrast 
deletion of the CGRP-specific polyadenylation site to- 
gether with a part of exon 5 and sequences downstream 
of it, disrupts this tissue specific splicing pattern and 
favours calcitonin-specific splicing even though intron 
4 and the CGRP splice acceptor at the 5’ end of exon 
5 are still present. 
Although poly(A) site selection has been shown not 
to be the primary regulatory event controlling the tissue 
specific splicing of the CALC-1 transcript [5], replace- 
ment of the CGRP-specific poly(A) site with that of 
SV40 may favour rapid usage of the calcitonin-specific 
poly(A) site resulting in the removal of exon 5 prior to 
the onset of splicing and hence favouring calcitonin- 
specific splicing. 
Alternatively, the deletion could act directly by affect- 
ing the splicing event itself either by interfering with the 
tissue specific regulation of the alternative splicing event 
or by reducing the utilization of the intron 4 splice sites 
by the general splicing machinery. Although in most 
cases the elements required for exon splicing are con- 
tained in the intervening intron [16] which would be 
present in the Cal-2 construct, there are a number of 
cases where exon sequences can also affect the splicing 
event. Thus the alternative splicing of several genes such 
as those encoding leukocyte common antigen [17], the 
Drosophila double sex gene [18] and the troponin T gene 
[ 191 can all be affected by alterations in the alternatively 
spliced exons themselves. Hence sequences in the distal 
part of the alternatively spliced exon 5 which is deleted 
in the Cal-2 construct might play a role in CALC-1 
alternative splicing acting either by binding a trans- 
acting factor or by promoting the correct folding of the 
RNA prior to splicing. 
It is clear therefore that sequences in the distal part 
of the CALC-1 gene are required for correct tissue- 
splicing, although further work will be required to iden- 
tify the mechanisms by which they act. Moreover, the 
existence of such distal sequences is likely to explain the 
anomalous behaviour of truncated constructs lacking 
these sequences when added to in vitro RNA processing 
systems. Thus in the experiments of Bovenberg et al. [9] 
a construct truncated within exon 5 underwent CGRP- 
specific splicing in HeLa cell extracts which naturally 
carry out calcitonin-specific splicing. In order to induce 
this construct to undergo calcitonin-specific splicing, it 
was necessary to mutate the sequence at the calcitonin- 
specific branch acceptor, leading to the suggestion that 
this motif may play a role in the regulation of alterna- 
tive splicing [IO]. In view of our experiments however, 
it is possible that this effect simply reflects the use of 
distally truncated constructs and would not be observed 
with constructs containing downstream sequences. 
Hence studies on the mechanism of CALC- 1 alternative 
splicing should not be carried out with constructs trun- 
cated in this region. 
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